RELMADA THERAPEUTICS INC

RLMDNASDAQ

🏆 #2481 by market capEarnings Nov 12US Equity

$4.47▼ $0.07 (−1.54%)

Market closed · at close

1h—

24h▼ 1.5%

7d▼ 17.8%

14d▼ 13.0%

30d▼ 30.6%

1y▲ 692.6%

🏦Market Cap

$469M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

43

Weak

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-0.11

Expected

-0.20

beat

+44.90%

YoY +63.30%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.11

beat

Q2 2026

-0.22

miss

Q1 2026

-0.27

miss

Q4 2025

-0.30

miss